Education
About Us
Working with TipRanks
Follow Us
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
Total Valuation
Aspen Pharmacare has a market cap or net worth of $2.57B. The enterprise value is $5.40B.
Market Cap$2.57B
Enterprise Value$5.40B
Share Statistics
Aspen Pharmacare has 446,252,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding446,252,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aspen Pharmacare’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 10.29%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)10.29%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee4.89M
Profits Per Employee162.06K
Employee Count8,867
Asset Turnover0.32
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of Aspen Pharmacare is 10.6. Aspen Pharmacare’s PEG ratio is ―.
PE Ratio10.6
PS Ratio―
PB Ratio―
Price to Fair Value0.00
Price to FCF―
Price to Operating Cash Flow8.28
PEG Ratio―
Income Statement
In the last 12 months, Aspen Pharmacare had revenue of 43.36B and earned -1.08B in profits. Earnings per share was -2.44.
Revenue43.36B
Gross Profit19.13B
Operating Income1.44B
Pretax Income-123.00M
Net Income-1.08B
EBITDA2.16B
Earnings Per Share (EPS)-2.44
Cash Flow
In the last 12 months, operating cash flow was 5.57B and capital expenditures -2.82B, giving a free cash flow of 2.75B billion.
Operating Cash Flow5.57B
Free Cash Flow2.75B
Free Cash Flow per Share6.16
Dividends & Yields
Aspen Pharmacare pays an annual dividend of $0.2, resulting in a dividend yield of 3.36%
Dividend Per Share$0.2
Dividend Yield3.36%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-44.61%
50-Day Moving Average6.40
200-Day Moving Average7.93
Relative Strength Index (RSI)42.10
Average Volume (3m)63.00
Important Dates
Aspen Pharmacare upcoming earnings date is Mar 5, 2026, TBA (Confirmed).
Last Earnings DateSep 3, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend DateSep 20, 2024
Financial Position
Aspen Pharmacare as a current ratio of 2.21, with Debt / Equity ratio of 41.69%
Current Ratio2.21
Quick Ratio1.18
Debt to Market Cap0.00
Net Debt to EBITDA13.75
Interest Coverage Ratio0.87
Taxes
In the past 12 months, Aspen Pharmacare has paid 960.00M in taxes.
Income Tax960.00M
Effective Tax Rate-7.80
Enterprise Valuation
Aspen Pharmacare EV to EBITDA ratio is 13.75, with an EV/FCF ratio of 285.68.
EV to Sales0.69
EV to EBITDA13.75
EV to Free Cash Flow285.68
EV to Operating Cash Flow5.76
Balance Sheet
Aspen Pharmacare has $6.80B in cash and marketable securities with $35.47B in debt, giving a net cash position of $28.67B billion.
Cash & Marketable Securities$6.80B
Total Debt$35.47B
Net Cash$28.67B
Net Cash Per Share$64.24
Tangible Book Value Per Share$0.00
Margins
Gross margin is 45.16%, with operating margin of 3.31%, and net profit margin of -2.50%.
Gross Margin45.16%
Operating Margin3.31%
Pretax Margin-0.28%
Net Profit Margin-2.50%
EBITDA Margin4.98%
EBIT Margin3.52%
Analyst Forecast
The average price target for Aspen Pharmacare is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside1.52% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-0.03%
EPS Growth Forecast-123.28%